Cross-linked hyaluronic acid gel occlusive device for the treatment of dry eye syndrome
John P Fezza Center for Sight, Sarasota, FL, USA Purpose: A new cross-linked hyaluronic acid (xlHA) gel occlusive device was assessed for safety and efficacy in the treatment of dry eyes.Methods: This was an institutional review board-approved, single-site, open-label, prospective study to assess...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2018
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/b384edc5614149358c1ce55e57fdb5b8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|